Der Nasdaq 100 ist neu zusammengesetzt worden !!! - 500 Beiträge pro Seite

[cantbelieve]

Eins vorweg, Palm ist nicht mehr mit von der Partie.
Wer hat Infos zu den NEUEN???
Und das sind die neuen Stars:

ImClone Systems Incorporated (IMCL) ,
Charter Communications, Inc. (CHTR) ,
CDW Computer Centers, Inc. (CDWC) ,
Symantec Corporation (SYMC) ,
Sepracor Inc. (SEPR) ,
Invitrogen Corporation (IVGN) ,
Express Scripts, Inc. (ESRX) ,
Cephalon, Inc. (CEPH) ,
ICOS Corporation (ICOS) ,
Cytyc Corporation (CYTC) ,
Protein Design Labs, Inc. (PDLI) ,
Integrated Device Technology, Inc. (IDTI) and
Synopsys, Inc. (SNPS)

[xenia1245]

IVGN ~ NEW YORK, Dec. 17 /PRNewswire/ -- The Nasdaq Stock Market announced today the annual re-ranking of the Nasdaq-100 Index(R), effective with the market open on Monday, December 24, 2001.

"The re-ranking is based on a number of objective criteria* with market capitalization a key factor," said John L. Jacobs, president and chief executive officer of Nasdaq Financial Products Services Inc., a subsidiary of Nasdaq. "We re-rank the index every year at this time and it is based on the number of shares outstanding and stock price. It reflects the current economy."

The following 13 issues will be added to the Nasdaq-100 Index: ImClone Systems Incorporated (Nasdaq: IMCL), Charter Communications, Inc (Nasdaq: CHTR), CDW Computer Centers, Inc. (Nasdaq: CDWC), Symantec Corporation (Nasdaq: SYMC), Sepracor Inc. (Nasdaq: SEPR), Invitrogen Corporation (Nasdaq: IVGN), Express Scripts, Inc. (Nasdaq: ESRX), Cephalon, Inc. (Nasdaq: CEPH), ICOS Corporation (Nasdaq: ICOS), Cytyc Corporation (Nasdaq: CYTC), Protein Design Labs, Inc. (Nasdaq: PDLI), Integrated Device Technology, Inc. (Nasdaq: IDTI) and Synopsys, Inc. (Nasdaq: SNPS).

"The Nasdaq-100 is the most sought after index by investors in the world. It`s composed of the premier non-financial growth companies in the economy and the index has become a financial benchmark for investors globally," said Jacobs. "In fact, it has outperformed every other major stock index in the U.S. for the 10 year period beginning December 1991, although past performance is not necessarily indicative of future performance."

"Unlike other major financial indices, the Nasdaq-100 is not a beauty contest," Jacobs continued. "Companies once dropped from the Index may rejoin it if their performance warrants because inclusion is based on objective criteria. This year, Synopsys, Inc. and Symantec Corporation are rejoining the Index. We welcome them back."

There are 23 domestic mutual funds and seven international funds linked to the Nasdaq-100 Index. Shares of each company in the Index are also included in the Nasdaq-100 Index Tracking Stock(SM) (Amex: QQQ), which represents ownership in the Nasdaq-100 Trust(SM). The Trust holds a portfolio of equity securities that comprise the Nasdaq-100 Index and aims to provide investment results that generally correspond with the Nasdaq-100 Index performance. Since its inception in March 1999, the Trust`s total assets have grown to over $22 billion.

The QQQ index tracking stock, which is an exchange-traded fund (ETF) that trades like a stock, is the world`s most actively traded ETF. On most trading days, it is also the second most actively traded security in the U.S.

The Nasdaq-100 Index is composed of the 100 largest non-financial stocks on the Nasdaq Stock Market and dates to January 1985 when it was launched along with the Nasdaq Financial-100 Index, which is the 100 largest financial stocks on Nasdaq. These indices were originally designed to segment Nasdaq into two major industry groups to support media coverage and to act as benchmarks for financial products such as options, futures, and funds.

The Nasdaq-100 is re-ranked in Dec each year, while the Nasdaq Financial-100 is re-ranked each June. Both re-rankings are timed to coincide with the respective triple witch options expiration Friday of the quarter.

"Scheduled re-rankings improve each indice`s value as a benchmark for investors and as metrics in the media and public domain," said Jacobs.

All securities in the Index are among the top 150 eligible securities by market capitalization based on closing prices as of October 31, 2001, and the publicly reported total shares outstanding as of Nov 30, 2001. Index securities which are already in the index and are in the top 150 eligible securities, are retained in the index, provided that such security was ranked in the top 100 eligible securities during the last year`s ranking. For more information about the Nasdaq-100 Index including eligibility criteria visit http://www.nasdaq-100.com .

As a result of the re-ranking of the Nasdaq-100 Index, the following 13 companies will be removed: Ariba, Inc (Nasdaq: ARBA), BroadVision, Inc. (Nasdaq: BVSN), CMGI, Inc. (Nasdaq: CMGI), CNET Networks, Inc. (Nasdaq: CNET), 3Com Corporation (Nasdaq: COMS), Inktomi Corporation (Nasdaq: INKT), Level 3 Communications, Inc. (Nasdaq: LVLT), McLeodUSA Incorporated (Nasdaq: MCLD), Metromedia Fiber Network, Inc. (Nasdaq: MFNX), Novell, Inc. (Nasdaq: NOVL), Palm, Inc. (Nasdaq: PALM), Parametric Technology Corporation (Nasdaq: PMTC) and RealNetworks, Inc. (Nasdaq: RNWK).

The Nasdaq-100 Index, launched in January 1985, has risen over 1100% percent since inception, although past performance is not necessarily indicative of future performance.

Annual adjustments were first implemented in 1993 in anticipation of Nasdaq-100 Index options trading on the Chicago Board Options Exchange in 1994 under the symbol "NDX." In April 1996, Nasdaq-100(R) futures and options on futures began trading on the Chicago Mercantile Exchange under the ticker "ND."

The Nasdaq Stock Market lists over 4,100 companies and trades more shares per day than any other US market. For more information about Nasdaq, visit the Nasdaq Web site at http://www.nasdaq.com or the Nasdaq Newsroom(SM) at http://www.nasdaqnews.com . For more information about the Nasdaq-100, visit http://www.nasdaq-100.com .

To learn more about the criteria for inclusion to the Nasdaq-100, visit http://dynamic.nasdaq.com/dynamic/nasdaq_financial100.stm .

Notes to editors:
The Trustee for the Nasdaq-100 Trust is required to adjust the composition of the Trust within three business days of the effective date of a change to the composition of the Nasdaq-100 Index.

While there is no assurance that the performance ofthe Nasdaq-100 Index can be fully matched, Nasdaq-100 Index Tracking Stock is designed to provide investment results that generally correspond to the performance of the Nasdaq-
100 Index.

For more complete information about the Nasdaq-100 Index Tracking Stock, including charges, expenses and potential risks, obtain a prospectus from your broker, or call 800-843-2639, or visit the Web site at http://www.nasdaq-100.com . Read it carefully before you invest.

The sponsor of the Nasdaq-100 Trust, a unit investment trust, is Nasdaq Financial Products Services, Inc ("NFPS"), a wholly owned subsidiary of The Nasdaq Stock Market, Inc. ("Nasdaq," and collectively with its affiliates except NFPS, the `Corporations"). Investment returns and principal value will fluctuate so that an investor`s shares, when redeemed or sold, may be worth more or less than the original cost.

ALPS Distributors, Inc., a registered broker-dealer, is distributor for the Trust.

"Nasdaq" and related marks are trademarks or service marks of Nasdaq and have been licensed for use for certain purposes by NFPS. The Nasdaq-100 Index is comprised and calculated by Nasdaq without regard to the Nasdaq-100 Index Tracking Stock. The Corporations make no warranty, express or implied, and bear no liability with respect to Nasdaq-100 Index Tracking Stock. The Corporations and NFPS make no warranty, express or implied, and bear no liability with respect to the Nasdaq-100 Index, its use or any data included therein. The Corporations do not guarantee the accuracy or the completeness of the Index, or any data used to calculate the index, or determine the index components.

Company briefs
The following are brief descriptions of the 13 companies added the Nasdaq- 100 Index in descending order based on market capitalization:

ImClone Systems Inc is developing a portfolio of targeted biologic treatments, designed to address the medical needs of patients with a variety of cancers. The company`s three programs include growth factor blockers, cancer vaccines and angiogenesis inhibitors. The NY, NY, company had a market capitalization of $4.4 billion at the time of ranking.

Charter Communications, Inc. provides a full range of advanced broadband services to the home, including cable television on an advanced digital video programming platform, high-speed Internet access, commercial high-speed data, video and Internet solutions, and advertising sales and production services. The St. Louis, MO, company had a market capitalization of $4.1 billion at the time of ranking.

CDW Computer Centers, Inc is a provider of multi-brand technology products and services for businesses, government agencies and educational institutions nationwide. The company`s relationship-based business model incorporates a dedicated account manager with support from technology specialist teams along with integrated online account and asset management tools. The Vernon Hills, IL, company had a market capitalization of $4 billion at the time of ranking.

Symantec Corp provides client, gateway and server security solutions for virus protection, firewall and virtual private network, vulnerability management, intrusion detection, Internet content and e-mail filtering, remote management technologies and security services to enterprises, consumers, and service providers around the world. The Cupertino, CA, company had a market capitalization of $3.7 billion at the time of ranking.

Sepracor Inc is a research-based pharmaceutical company dedicated to treating and preventing human disease through the discovery, development, and commercialization of innovative pharmaceutical products that are directed toward serving unmet medical needs. The company`s drug development program has yielded a portfolio of pharmaceutical candidates that are focused on the treatment of respiratory, urological, and central nervous system disorders. The Marlborough, MA, company had a market capitalization of $3.6 billion at the time of ranking.

Invitrogen Corp develops, manufactures and markets research tools in kit form and provides other research products and services to biotechnology and biopharmaceutical researchers and companies worldwide. The company manufactures and markets thousands of products and services that simplify and improve gene cloning, gene expression, and gene analysis techniques for corporate, academic and government entities. The San Diego, CA, company had a market capitalization of $3.2 billion at the time of ranking.

Express Scripts, Inc is an independent, full-service pharmacy benefit manager (PBM). The company provides fully integrated PBM services, mail-order pharmacy services, benefit design consultation; disease management; medical and drug data analysis services; and medical information management services. The company also provides distribution services of specialty pharmaceuticals through its Specialty Distribution subsidiary. The St Louis, MO, company had a market capitalization of $3.2 billion at the time of ranking.

Cephalon, Inc is an international biopharmaceutical company that discovers, develops and markets products to treat neurological and sleep disorders, cancer and pain. The company develops innovative products for the treatment of neurological diseases and cancer through identification of novel compounds that affect both cell survival and death. The West Chester, PA, company had a market capitalization of $3.1 billion at the time of ranking.

ICOS Corporationy that has expertise in both protein-based and small molecule therapeutics. The company combines its capabilities in molecular, cellular and structural biology, high throughput drug screening, medicinal chemistry and gene expression profiling to develop highly innovative products with significant commercial potential. The Bothwell, WA, company had amarket capitalization of $3.1 billion at the time of ranking.

Cytyc Corp develops, manufactures, and markets products for medical diagnostic applications primarily focused on women`s health. Cytyc`s ThinPrep(R) System is widely used for cervical cancer screening and will form the platform for the Company`s expansion into breast cancer risk assessment. The Boxborough, MA, company had a market capitalization of $3 billion at the time of ranking.

Protein Design Labs, Inc. develops humanized antibodies to prevent or treat various disease conditions. The company currently has antibodies under development for autoimmune and inflammatory conditions, asthma and cancer. Protein Design Labs holds fundamental patents in the US, Europe and Japan for its antibody humanization technology. The Fremont, CA, company had a market capitalization of $2.9 billion at the time of ranking.

Integrated Device Technology, Inc. enhances the global network with semiconductor solutions for communication companies. The company`s communications-specific products include integrated processors, IP co-processors and telecom products; its foundational product portfolio is comprised of a selection of FIFOs, multi-ports, and clock management products; and the company`s product mix also incorporates high-performance digital logic and SRAMs to meet the requirements of communications systems. The Santa Clara, CA, company had a market capitalization of $2.9 billion at the time of ranking.

Synopsys, Inc creates electronic design automation (EDA) tools for the global electronics market. The company delivers advanced design technologies and solutions to developers of complex integrated circuits, electronic systems, and systems on a chip. Synopsys also provides consulting and support services. The Mountain View, CA, company had a market capitalization of $2.7 billion at the time of ranking.

[hugo_b]

Infos zu CEPH: Thread: Kein Titel für Thread 52245110
Infos zu IMCL: Thread: Kein Titel für Thread 52245119
Infos zu SEPR: Thread: Kein Titel für Thread 52245135